hide message

Hello! Welcome to the Resource Centre.

We hope you find our free tools and resources useful. Did you know we also work directly with community advocates, providing them with the skills and resources to document corporate human rights abuses and effectively communicate with business?

This is only possible through generous donations from people like you.

Please consider supporting our work.

Thank you,
Phil Bloomer, Executive Director

Donate now hide message

ICCR AIDS report & responses

Interfaith Center on Corporate Responsibility report "Benchmarking AIDS": Company responses

In August 2006, the Interfaith Center on Corporate Responsibility (ICCR) issued a report, "Benchmarking AIDS: Evaluating pharmaceutical company responses to the public health crisis in emerging markets".  A PowerPoint summary of the report, which includes scores and "bottom line" assessment of each company, is available here.  The Business & Human Rights Resource Centre invited the 15 benchmarked companies to respond to the report; the results to date are indicated below.  Below the companies' responses are rejoinders by ICCR and Physicians for Social Justice (Nigeria) to the companies' responses, and a November 2006 follow-up report by ICCR.

Company responses / non-responses:

Abbott Laboratories statement [DOC]

AstraZeneca response [DOC]

Boehringer-Ingelheim response [DOC]

Bristol-Myers Squibb response [DOC]

Eli Lilly - declined to respond

Gilead Sciences - declined to respond

GlaxoSmithKline response [DOC]

Hoffman-La Roche - declined to respond

Merck response [PDF]

Novartis response [DOC]

Pfizer response [PDF]

sanofi-aventis - declined to respond

Schering-Plough - declined to respond

Tibotec (part of Johnson & Johnson) response [DOC]

Wyeth - press release sent in response to ICCR report

Rejoinders:

ICCR statement regarding the company responses (6 Nov 2006) [DOC]

Physicians for Social Justice (Nigeria) rejoinder to the company responses [DOC]
- Novartis response to Physicians for Social Justice [DOC]

Nov 2006 ICCR update:

Benchmarking AIDS: 2006 Year End Update [PDF]
- includes recent steps taken by Abbott, Gilead, GlaxoSmithKline, Novartis, Roche & recommendations for next steps for each of these companies

Get RSS feed of these results

Related stories and components

Company non-response
4 March 2014

Schering-Plough did not respond to: Interfaith Center on Corporate Responsibility rates 15 pharmaceutical firms on HIV/AIDS, including Schering-Plough - finds none has comprehensive approach.

Read more

Company response
13 September 2006

Response by Bristol-Myers Squibb: Interfaith Center on Corporate Responsibility rates 15 pharmaceutical firms on HIV/AIDS, including Bristol-Myers Squibb - finds none has comprehensive approach.

Read full response

Company response
13 September 2006

Response by Merck: Interfaith Center on Corporate Responsibility rates 15 pharmaceutical firms on HIV/AIDS, including Merck - finds none has comprehensive approach.

Read full response

Company response
13 September 2006

Response by Wyeth (part of Pfizer): Interfaith Center on Corporate Responsibility rates 15 pharmaceutical firms on HIV/AIDS, including Wyeth - finds none has comprehensive approach.

Read full response

Article
12 September 2006

Company responses to Interfaith Center on Corporate Responsibility report "Benchmarking AIDS"

Author: Compiled by Business & Human Rights Resource Centre

In August 2006, the Interfaith Center on Corporate Responsibility issued a report, "Benchmarking AIDS: Evaluating pharmaceutical company responses to the public health crisis in emerging markets"...The Business & Human Rights Resource Centre...

Read more

Company response
6 September 2006

Response by AstraZeneca: Interfaith Center on Corporate Responsibility rates 15 pharmaceutical firms on HIV/AIDS, including AstraZeneca - finds none has comprehensive approach.

Read full response

Company response
6 September 2006

Response by Boehringer Ingelheim: Interfaith Center on Corporate Responsibility rates 15 pharmaceutical firms on HIV/AIDS, including Boehringer-Ingelheim - finds none has comprehensive approach.

Read full response

Company non-response
23 August 2006

Eli Lilly did not respond to: Interfaith Center on Corporate Responsibility rates 15 pharmaceutical firms on HIV/AIDS, including Eli Lilly - finds none has comprehensive approach.

Read more

Company response
23 August 2006

Response by Novartis: Interfaith Center on Corporate Responsibility rates 15 pharmaceutical firms on HIV/AIDS, including Novartis - finds none has comprehensive approach.

Read full response

Company response
23 August 2006

Response by Pfizer: Interfaith Center on Corporate Responsibility rates 15 pharmaceutical firms on HIV/AIDS, including Pfizer - finds none has comprehensive approach.

Read full response